FDA approves combo eye drop for glaucoma
• Drug News •
• Eye / Vision Problems •
Oct 31, 07
|
U.S. regulators approved a new glaucoma treatment—Combigan, an eye drop that treats the potentially blinding eye condition with two drugs that work through different mechanisms, Allergan Inc said Wednesday.
Allergan, best known for its Botox anti-wrinkle drug but is also a leading provider of eye medications and products, said its new drug would be introduced in the fourth quarter of 2007.
The company said Combigan would combine “two strong agents in one bottle”—brimonidine and timolol—to control pressure within the eye that can harm the optic nerve.
Print Version
Tell-a-Friend comments powered by Disqus